ERIN CALHOUN: Open Payments
NPI 1790461531 · ELBRIDGE, NY. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$678 in 33 payments from 16 companies in 2025. Trend: 2023 $334 · 2024 $1,035 · 2025 $678
Food & beverage: $678
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 4 | $100 |
| Lilly USA, LLC | 5 | $96 |
| Novo Nordisk Inc | 4 | $94 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 3 | $54 |
| Exact Sciences Corporation | 2 | $43 |
| Lundbeck LLC | 2 | $40 |
| PFIZER INC. | 2 | $36 |
| Amgen Inc. | 2 | $35 |
| Baxter Healthcare | 1 | $34 |
| AstraZeneca Pharmaceuticals LP | 2 | $28 |
Products named: MOUNJARO, JARDIANCE, Ozempic, QULIPTA, Cologuard Collection Kit, VYEPTI, OTEZLA, Hillrom - Carnation Ambulatory Monitor.
Industry payments across NY — which companies pay providers there.
